IMNM

Immunome is a biotechnology company that develops cancer drugs. The company is testing several experimental treatments, including Varegacestat for desmoid tumors (a type of tumor) and IM-1021, which combines an antibody with a cancer-fighting drug to attack tumor cells. Most of these treatments are still in early testing stages in humans. The company is based in Washington State and was founded in 2006.